Photo via Reason

Rep. Steve Cohen Thinks the DEA Shouldn't Be Practicing Medicine

Read the original at Reason ↗
Cite

Singer, J. A. (2026, October 29). Rep. Steve Cohen Thinks the DEA Shouldn't Be Practicing Medicine. Reason. https://reason.com/2026/10/29/rep-steve-cohen-thinks-the-dea-shouldnt-be-practicing-medicine/

Dated from the outlet's own feed. Check the original for its byline.

Reason · collected 2026-10-29 · by Jeffrey A. Singer

Quick Summary

Rep. Steve Cohen has proposed the Public Health and Research Reforms in Controlled Substances Act of 2026 to overhaul federal drug classification laws. The bill suggests shifting decision-making authority from the Drug Enforcement Administration (DEA) to the Department of Health and Human Services (HHS), which would assess medical usefulness and risks more objectively. Cohen's proposal includes descheduling marijuana, easing research restrictions, and revising criteria for adding substances to controlled schedules based on potential to cause substance use disorder rather than just abuse potential. This move aims to create a more rational drug policy that prioritizes public health over strict prohibition.
Written by AI on 2026-11-01, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Rep. Steve Cohen (D–Tenn.) has proposed a bill called the Public Health and Research Reforms in Controlled Substances Act of 2026, which aims to overhaul federal drug scheduling by shifting decision-making authority from the Drug Enforcement Administration (DEA) to health officials within the Department of Health and Human Services (HHS). The bill would ease research restrictions, deschedule marijuana, and reduce mandatory prison penalties for certain offenses. Currently, under the Controlled Substances Act, the DEA makes the ultimate legal determination on whether a drug has "currently accepted medical use," despite HHS evaluating scientific evidence. Cohen's proposal seeks to separate these roles to create a more rational, evidence-based approach to drug policy.

Written for “DEA Medical Practices Criticized” on 2026-11-01, grounded in this article and the 0 other(s) covering the same event.
Why this leaning score
The article's own words the score was based on. Each is quoted verbatim and was checked against the article text before being stored, so you can find it in the original.
Reading Leans strongly left (beta estimate) Confidence high
Leaning: leans strongly left for article 115521 (high confidence, 3 verified quotes) · logged 2026-11-01

Story

📰 DEA Medical Practices Criticized
Politics · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
69
sentences that state something as happening or true
Uncertain
9%
6 of 69 hedged ("reportedly", "may", "according to")
Leaning
Leans strongly left
of the writing, not the subject · beta estimate
Publisher signals
67/100
Reason's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-01 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Reason · 1046 article(s) · 4 correction(s) detected
Running correction rate · 4 correction(s)

Who wrote this

Jeffrey A. Singer
4 article(s) here · 1 carrying a prediction
🔮 His Public Health and Research Reforms in Controlled Substances Act of 2026 would substantially overhaul federal drug scheduling, shift key decisions from law enforcement to health officials, ease research restrictions, deschedule marijuana, and reduce mandatory prison penalties.
🔮 Patients diagnosed with progressive dementia may know exactly how much deterioration they are willing to endure.
🔮 Depending on the employer's plan, patients who choose a Garner-recommended doctor may get reimbursed for some or all of their copays, coinsurance, or deductible expenses.
🔮 Anyone born after January 1, 2006, will never be old enough to legally buy nicotine products there.
Also by Jeffrey A. Singer
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

DEA HHS Public Health and Research Reforms in Controlled Substances Act Tenn. The Controlled Substances Act

Subjects

DEA ORG · 2× HHS ORG · 2× Cohen PERSON · 1× Congress ORG · 1× Roman NORP · 1× Steve Cohen PERSON · 1× Tenn. GPE · 1× The Department of Health and Human Services ORG · 1× the Drug Enforcement Administration ORG · 1× the Justice Department ORG · 1×

Narrative

The Department of Health and Human Services (HHS) evaluates the scientific and medical evidence, but the DEA makes the ultimate legal determination of whether a drug has a "currently accepted medical use" for scheduling purposes, as the Justice Department explained in a 2024 legal opinion.
framing: assertive · carried by 1 article(s) · first seen 2026-11-01
🔮 His Public Health and Research Reforms in Controlled Substances Act of 2026 would substantially overhaul federal drug scheduling, shift key decisions from law enforcement to health officials, ease research restrictions, deschedule marijuana, and reduce mandatory prison penalties.
2026-11-01 · Reason
Rep. Steve Cohen Thinks the DEA Shouldn't Be Practicing Medicine · assertive framing

Claims (69 extracted, 6 hedged)

For more than half a century, federal officials have classified drugs into legal categories that determine who can manufacture, prescribe, or study them, and who goes to prison for possessing or selling them. asserted
who → classify → them
Those classifications carry enormous consequences. asserted
classifications → carry → consequences
They also reflect decades of political pressure, moralization, myth, and stigma. asserted
They → reflect → pressure
Rep. Steve Cohen (D–Tenn.) proposes to change that. asserted
Cohen → propose → that
His Public Health and Research Reforms in Controlled Substances Act of 2026 would substantially overhaul federal drug scheduling, shift key decisions from law enforcement to health officials, ease research restrictions, deschedule marijuana, and reduce mandatory prison penalties. asserted
Act → overhaul → penalties
While the proposal preserves too much of the drug prohibition infrastructure, it represents a major step toward a more rational, evidence-based, and humane drug policy. asserted
it → preserve → policy
The Controlled Substances Act currently combines judgments about a drug's potential for abuse with judgments about its medical usefulness. asserted
Act → combine → usefulness
Congress vested scheduling authority in the attorney general, who generally exercises it through the Drug Enforcement Administration (DEA). asserted
who → vest → Administration
The Department of Health and Human Services (HHS) evaluates the scientific and medical evidence, but the DEA makes the ultimate legal determination of whether a drug has a "currently accepted medical use" for scheduling purposes, as the Justice Department explained in a 2024 legal opinion. asserted
Department → evaluate → opinion
Schedule I, the most restrictive category, includes substances deemed to have a high potential for abuse and no currently accepted medical use. asserted
I → include → abuse
These restrictions impede research, while officials cite insufficient evidence of medical usefulness to justify continued restrictions. asserted
officials → impede → restrictions
Cohen's bill would transfer authority to assess medical usefulness and drug-related risks—and to make scheduling decisions—from law enforcement to HHS, where those judgments more rationally belong. asserted
judgments → transfer → HHS
Under the new system, controlled substances would receive two classifications: a Roman numeral, I through IV, reflecting risks associated with misuse, substance use disorder, and threats to public health; and a letter, A through E, reflecting therapeutic value. asserted
substances → receive → value
A substance could therefore be classified as high risk while still recognized for substantial medical benefits. uncertain
substance → classify → benefits
That reflects an everyday reality of medical practice. asserted
That → reflect → practice
Fentanyl, for example, can cause fatal respiratory depression and remains an indispensable anesthetic and analgesic. asserted
Fentanyl → cause → depression
A drug's dangers do not erase its benefits. asserted
dangers → erase → benefits
The bill would also replace the vague "potential for abuse" standard for adding substances to the schedules with a standard based on the potential to develop a substance use disorder, expressly excluding isolated or occasional nontherapeutic use. asserted
bill → replace → use
Taking a substance for pleasure would no longer, by itself, satisfy that threshold. asserted
Taking → take → threshold
Among the proposal's most consequential provisions is a requirement that officials consider whether scheduling a substance would itself threaten public health, including by encouraging people to substitute other drugs. asserted
scheduling → consider → drugs
They must also consider whether people use a substance to help control problematic use of another scheduled drug, as well as the harms associated with that other drug. asserted
people → consider → drug
That would force federal officials to confront consequences that drug warriors routinely ignore. asserted
warriors → force → that
Banning a substance does not eliminate demand. asserted
Banning → ban → demand
Consumers may turn to underground suppliers, face uncertain potency and contamination, or switch to more dangerous products. uncertain
Consumers → turn → products
Making a particular drug harder to obtain can leave its users worse off. asserted
drug → make → users
These requirements could be critical in disputes over kratom and its alkaloids, such as 7-hydroxymitragynine (7-OH), which some consumers report using for pain or to reduce their use of other opioids. uncertain
consumers → use → opioids
Such reports should be part of an honest assessment of what consumers stand to lose when the government closes a legal supply channel. asserted
government → stand → channel
An expert committee would evaluate each substance and publish its evidence and reasoning, making scheduling decisions more transparent and easier to challenge. asserted
decisions → evaluate → evidence
HHS would also assume from the DEA responsibility for registering researchers who study controlled substances. asserted
who → assume → substances
Qualifying researchers would gain an expedited registration pathway, with faster decisions for eligible small preclinical pilot studies. asserted
researchers → gain → studies
Federal officials currently demand evidence that these drugs have medical benefits while imposing restrictions that make it harder for researchers to obtain the drugs and conduct the studies needed to generate that evidence. asserted
researchers → demand → evidence
Cohen would require officials to reconsider existing classifications, setting a two-year deadline for 32 named substances and an eight-year deadline for most others. asserted
Cohen → require → others
If officials miss those deadlines, statutory fallback classifications would apply. asserted
classifications → miss → deadlines
The bill would also repeal the legal obligation of the director of the Office of National Drug Control Policy, the "drug czar," to oppose specified legalization efforts—a remarkable requirement for an office supposedly focused on evaluating drug policy. asserted
bill → repeal → policy
Marijuana and tetrahydrocannabinols (THCs) would come off the controlled substance schedules altogether. asserted
Marijuana → come → schedules
The bill expressly makes that change retroactive, extending it to past offenses, pending cases, convictions, and juvenile adjudications. asserted
change → make → offenses
Its sentencing reforms also merit praise. asserted
reforms → merit → praise
The proposal would remove the quantity-based trafficking provisions that impose five- and 10-year mandatory minimums and eliminate specified mandatory penalties when death or serious injury results. asserted
death → remove → penalties
The bill would also limit certain repeat-offender sentencing enhancements to prior convictions that meet the narrower definition of a "serious drug felony." asserted
that → limit → felony
Among other requirements, the person must have served more than a year in prison and been released within 15 years of the new offense. asserted
person → serve → offense
…and 29 more, not listed.
💬Give feedback
🕘History 🎫Support